A national Medicare coverage policy is now set for transcatheter aortic valve replacement (TAVR), stabilizing the reimbursement environment for the new procedure, but also establishing a level of payor restrictions that is rare for a technology so early in its life cycle.
The TAVR procedure, an alternative to open heart valve surgery, is being touted as practice-changing by cardiologists and a blockbuster business opportunity for device companies. The Centers for Medicare and...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?